Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study
Liver International · 2024-08 · 44 (8) · 2038-2053
DOI: 10.1111/liv.15945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 25.04.2024. Verfasst von Paul-Henry Koop und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Comorbidity, Metabolome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Federal Ministry of Education and Research, Ministry of Culture and Science of the German State of North Rhine-Westphalia, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Background and Aims Primary biliary cholangitis (PBC) is a chronic, immune‐mediated liver disease that can lead to fibrosis and cirrhosis. In this cohort study, we aimed to investigate morbidity and mortality in conjunction with metabolomic changes of PBC in a UK population‐based cohort.
Methods
454 participants with PBC and 908 propensity score (age, sex, BMI, ethnicity) matched controls without liver disease were included in the study. A subset of participants with PBC and controls were analysed for their metabolomic profile. Further, PBC‐associated comorbidities were investigated by PheWAS analysis. Lastly, we assessed causes of death in individuals with PBC using a Fine and Grey competing‐risks regression model.
Results
Compared to the control group, various pathways associated with the metabolism of amino acids, lipids, and liver biochemistry were significantly enriched in individuals with PBC. We found reduced levels of S‐HDL‐cholesterol and Glycoprotein Acetyls in individuals with PBC as well as an association with diseases of the circulatory system. Notably, PBC individuals had a higher prevalence of digestive diseases, autoimmune diseases, cardiovascular diseases, anaemias, mental disorders, and urinary tract infections compared to the control group. Strikingly, the overall mortality was almost three times higher in the PBC group compared to the control group, with diseases of the digestive system accounting for a significant elevation of the death rate. A subsequent analysis, enhanced by propensity score matching that included the APRI score, demonstrated that the observed morbidity could not be exclusively attributed to advanced hepatic disease.
Conclusions
Our study provides a detailed perspective on the morbidity of individuals with PBC. The exploration of potential effects of disease state on morbidity suggest that early detection and early treatment of PBC could enhance patient prognosis and prevent the onset of comorbid diseases. Finally, the metabolomic alterations could represent a link between the pathophysiological processes underlying PBC development, progression, and associated morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
- The Institute for Translational Medicine and Therapeutics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Paul-Henry Koop, Jan Clusmann, Mara S Vell, Julius Jaeger, Christian Trautwein, Tony Bruns, Carolin V Schneider, Kai Markus Schneider
Förderung
- Federal Ministry of Education and Research
- Ministry of Culture and Science of the German State of North Rhine-Westphalia
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Koop, P. H., Schwenzer, C., Clusmann, J., Vell, M. S., Jaeger, J., Gui, W., Trautwein, C., Koch, A., Bruns, T., Schneider, C. V., & Schneider, K. M. (2024). Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study. Liver International, 44(8), 2038-2053. https://doi.org/10.1111/liv.15945
Vancouver
Koop PH, Schwenzer C, Clusmann J, Vell MS, Jaeger J, Gui W, et al. Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study. Liver International. 2024;44(8):2038-2053. doi:10.1111/liv.15945
BibTeX
@article{Koop2024,
author = {Koop, Paul-Henry and Schwenzer, Constanze and Clusmann, Jan and Vell, Mara S and Jaeger, Julius and Gui, Wenfang and Trautwein, Christian and Koch, Alexander and Bruns, Tony and Schneider, Carolin V and Schneider, Kai Markus},
title = {Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study},
journal = {Liver International},
year = {2024},
volume = {44},
number = {8},
pages = {2038--2053},
doi = {10.1111/liv.15945}
}
EUVIMED